Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Rocket Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of RP-L102 in the U.S.

firstwordpharmaMarch 13, 2019

Tag: Rocket Pharmaceuticals , First patient , Clinical Trial

PharmaSources Customer Service